- Home
- FDSB vs SLRX Comparison
FDSB vs SLRX Comparison
Compare FDSB & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDSB
- SLRX
- Stock Information
- Founded
- FDSB 1926
- SLRX N/A
- Country
- FDSB United States
- SLRX United States
- Employees
- FDSB N/A
- SLRX N/A
- Industry
- FDSB
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- FDSB
- SLRX Health Care
- Exchange
- FDSB NYSE
- SLRX Nasdaq
- Market Cap
- FDSB 69.2M
- SLRX 1.8M
- IPO Year
- FDSB N/A
- SLRX N/A
- Fundamental
- Price
- FDSB $12.25
- SLRX $0.92
- Analyst Decision
- FDSB
- SLRX
- Analyst Count
- FDSB 0
- SLRX 0
- Target Price
- FDSB N/A
- SLRX N/A
- AVG Volume (30 Days)
- FDSB 13.5K
- SLRX 3.5M
- Earning Date
- FDSB 08-15-2025
- SLRX 08-08-2025
- Dividend Yield
- FDSB N/A
- SLRX N/A
- EPS Growth
- FDSB N/A
- SLRX N/A
- EPS
- FDSB 0.02
- SLRX N/A
- Revenue
- FDSB $12,612,000.00
- SLRX N/A
- Revenue This Year
- FDSB N/A
- SLRX N/A
- Revenue Next Year
- FDSB N/A
- SLRX N/A
- P/E Ratio
- FDSB $515.94
- SLRX N/A
- Revenue Growth
- FDSB 40.41
- SLRX N/A
- 52 Week Low
- FDSB $9.85
- SLRX $0.45
- 52 Week High
- FDSB $14.50
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- FDSB N/A
- SLRX 55.98
- Support Level
- FDSB N/A
- SLRX $0.61
- Resistance Level
- FDSB N/A
- SLRX $1.33
- Average True Range (ATR)
- FDSB 0.00
- SLRX 0.14
- MACD
- FDSB 0.00
- SLRX 0.03
- Stochastic Oscillator
- FDSB 0.00
- SLRX 52.84
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.